PE Firm Actis Sinks $48M Into India's Symbiotec Pharmalab
Private equity house Actis LLP will invest $48 million into India-based pharmaceutical company Symbiotec Pharmalab Ltd., the firm said Tuesday....To view the full article, register now.
Already a subscriber? Click here to view full article